TRIEU VUONG (CEO and Chairman of the Board) purchased 0.0% of their position (3K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $360.00 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/27/2020ACC: 0001415889-20-000880
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+3K
Net shares
Net buyer
$360.00
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3K
Price / share
$0.12
Trade value
$360.00
% of position
0.0%
3/26/2020
15.76M→15.76M
Total
Net shares
+3K
Net value
$360.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2020 | P · Purchase | +3K | $0.12 | $360.00 | 0.0% | 15.76M | 15.76M |
| Total | +3K | $360.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2.93M
Common Stock
IndirectShares owned1.20M
Total
4.13M indirect4.13M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.93M | Indirect |
| Common Stock | 1.20M | Indirect |
| Total | 4.13M | 4.13M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported